ROCHE HOLDING AG News

Notable Healthcare Headlines for the Week: Merck, Roche and Bausch Health in Focus

Seeking AlphaApr 27 14:10 ET

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and VYNE Therapeutics (VYNE)

TipRanksApr 25 21:50 ET · Ratings

Genentech's Xofluza Demonstrates 32% Reduction In Household Transmission Of Influenza In Global Phase III Trial

BenzingaApr 25 02:37 ET

Zealand Pharma Gains as Trial for Roche-partnered Obesity Drug Starts

Seeking AlphaApr 24 13:38 ET

EU Pharma Majors Sanofi, Roche Trade Flat After Reiterated Guidance

Seeking AlphaApr 24 08:36 ET

Roche Holding AG (RHHVF) Receives a Buy From DZ BANK AG

TipRanksApr 24 08:05 ET · Ratings

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

WSJApr 24 05:24 ET

Roche's Results Are Solid -- Market Talk

WSJApr 24 05:18 ET

Jefferies Keeps Their Hold Rating on Roche Holding AG (RHHVF)

TipRanksApr 24 04:05 ET · Ratings

Roche Sales Rise Boosted By Key Drugs

WSJApr 24 01:16 ET

Roche Logs Growth in Q1 Sales; Affirms FY25 Outlook

MT NewswiresApr 24 01:15 ET

Roche Backs 2025 View

Dow JonesApr 24 01:03 ET

Roche Diagnostics Division 1Q Sales Flat at Constant Currency

Dow JonesApr 24 01:03 ET

Roche 1Q Sales CHF15.44B

Dow JonesApr 24 01:02 ET

Analysts Saw Roche 1Q Sales at CHF15.33B

Dow JonesApr 24 01:02 ET

European pharmaceutical giants are calling for an increase in pharmaceutical prices to the same level as in the USA.

The CEOs of the two major pharmaceutical giants in Europe, Novartis and Sanofi, stated in an open letter on Wednesday that in order to attract investment, the EU should allow pharmaceutical prices to rise to the levels found in the USA. Pharmaceutical prices in the USA are the highest in the world, often nearly three times that of other developed countries. Novartis CEO Vas Narasimhan and Sanofi CEO Paul Hudson wrote, "Price controls and austerity measures in Europe have reduced the attractiveness of its market." They added, "In the context of declining biopharmaceutical competitiveness in Europe, uncertainty about tariffs further diminishes the motivation to invest in the EU." They believe that EU

Global market reportApr 23 02:58 ET

Roche's Chest Pain Triage Algorithm Receives CE Mark

MT NewswiresApr 23 02:10 ET

Roche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs

BenzingaApr 22 15:21 ET

Roche will invest 50 billion US dollars in the United States over the next five years to enhance research and production capabilities.

① The Swiss Franc healthcare giant Roche announced plans to invest 50 billion USD in the USA over the next five years, creating over 0.012 million new jobs. ② Roche's investment plan is being carried out against the backdrop of the Trump administration initiating an investigation into imported Pharmaceuticals, which could be a precursor to the USA imposing tariffs on the Industry.

cls.cnApr 22 06:09 ET

Roche's $50 Billion US Investment Commitment Includes New Facilities, 12,000 Jobs, Expanded R&D Hubs As Drug Tariffs Loom

BenzingaApr 22 05:53 ET